Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study Article

International Collaboration

author list

  • Lebwohl, M. G.; Stein Gold, L.; Papp, K.; Han, G.; Pariser, D. M.; Lin, T.; Harris, S.; Jacobson, A.

publication date

  • February 7, 2021